MFFIA
CLMT icon

McIntyre, Freedman & Flynn Investment Advisers’s Calumet Specialty Products CLMT Stock Holding History

McIntyre, Freedman & Flynn Investment Advisers’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Hold
6,000
– – 0.13% 78
2026
Q1 		$215K Buy
+6,000
New +$155K 0.12% 76
2024
Q3 		– Sell
-11,500
Closed -$185K – 72
2024
Q2 		$185K Hold
11,500
– – 0.13% 62
2024
Q1 		$171K Buy
+11,500
New +$183K 0.12% 60

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McIntyre, Freedman & Flynn Investment Advisers's CLMT Position: Q2 2026 in Review

McIntyre, Freedman & Flynn Investment Advisers held its Calumet Specialty Products (CLMT) position steady in Q2 2026 at 6,000 shares worth $216K. The position accounts for 0.13% of the portfolio, ranked #78.

McIntyre, Freedman & Flynn Investment Advisers first reported a position in CLMT in Q1 2024 and has held it in 4 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • McIntyre, Freedman & Flynn Investment Advisers held 6,000 shares of Calumet Specialty Products worth $216K as of Q2 2026.
  • McIntyre, Freedman & Flynn Investment Advisers left its Calumet Specialty Products share count unchanged in Q2 2026.
  • Calumet Specialty Products made up 0.13% of McIntyre, Freedman & Flynn Investment Advisers's portfolio in Q2 2026, its #78 holding.
  • McIntyre, Freedman & Flynn Investment Advisers first reported a position in Calumet Specialty Products in Q1 2024 and has held it in 4 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on McIntyre, Freedman & Flynn Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.